BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

868 related articles for article (PubMed ID: 30550238)

  • 21. Antimicrobial susceptibility of Gram-negative ESKAPE pathogens isolated from hospitalized patients with intra-abdominal and urinary tract infections in Asia-Pacific countries: SMART 2013-2015.
    Karlowsky JA; Hoban DJ; Hackel MA; Lob SH; Sahm DF
    J Med Microbiol; 2017 Jan; 66(1):61-69. PubMed ID: 28051952
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Randomized controlled trial of piperacillin-tazobactam, cefepime and ertapenem for the treatment of urinary tract infection caused by extended-spectrum beta-lactamase-producing Escherichia coli.
    Seo YB; Lee J; Kim YK; Lee SS; Lee JA; Kim HY; Uh Y; Kim HS; Song W
    BMC Infect Dis; 2017 Jun; 17(1):404. PubMed ID: 28592240
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and microbiologic analysis of a hospital's extended-spectrum beta-lactamase-producing isolates over a 2-year period.
    Burgess DS; Hall RG; Lewis JS; Jorgensen JH; Patterson JE
    Pharmacotherapy; 2003 Oct; 23(10):1232-7. PubMed ID: 14594340
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antimicrobial susceptibility pattern of bacteria isolated from patients with urinary tract infection.
    Khan IU; Mirza IA; Ikram A; Afzal A; Ali S; Hussain A; Fayyaz M; Ghafoor T
    J Coll Physicians Surg Pak; 2014 Nov; 24(11):840-4. PubMed ID: 25404444
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Relationships between antimicrobial use and antimicrobial resistance in Gram-negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan.
    Hsueh PR; Chen WH; Luh KT
    Int J Antimicrob Agents; 2005 Dec; 26(6):463-72. PubMed ID: 16280243
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Antibiotic resistance rates of extended spectrum beta-lactamase producing Escherichia coli and Klebsiella spp. strains isolated from urinary tract infections in a private hospital].
    Akyar I
    Mikrobiyol Bul; 2008 Oct; 42(4):713-5. PubMed ID: 19149097
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Community-associated urinary infections requiring hospitalization: risk factors, microbiological characteristics and patterns of antibiotic resistance.
    Medina-Polo J; Guerrero-Ramos F; Pérez-Cadavid S; Arrébola-Pajares A; Sopeña-Sutil R; Benítez-Sala R; Jiménez-Alcaide E; García-González L; Alonso-Isa M; Lara-Isla A; Passas-Martínez JB; Tejido-Sánchez Á
    Actas Urol Esp; 2015 Mar; 39(2):104-11. PubMed ID: 25301702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Risk factors for ciprofloxacin resistance among Escherichia coli strains isolated from community-acquired urinary tract infections in Turkey.
    Arslan H; Azap OK; Ergönül O; Timurkaynak F;
    J Antimicrob Chemother; 2005 Nov; 56(5):914-8. PubMed ID: 16174685
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Susceptibility patterns of Escherichia coli: prevalence of multidrug-resistant isolates and extended spectrum beta-lactamase phenotype.
    Iqbal M; Patel IK; Shah SH; Ain Q; Barney N; Kiani Q; Rabbani KZ; Zaidi G; Mehdi B
    J Pak Med Assoc; 2002 Sep; 52(9):407-11. PubMed ID: 12532575
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO·SENS study revisited.
    Kahlmeter G; Poulsen HO
    Int J Antimicrob Agents; 2012 Jan; 39(1):45-51. PubMed ID: 22055529
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Antimicrobial susceptibility pattern of nosocomial gram negative pathogens: results from MYSTIC study in Hacettepe University Adult Hospital (2000-2004)].
    Zarakolu P; Hasçelik G; Unal S
    Mikrobiyol Bul; 2006 Jul; 40(3):147-54. PubMed ID: 17001842
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary tract infection trends in Latin American hospitals: report from the SENTRY antimicrobial surveillance program (1997-2000).
    Gales AC; Sader HS; Jones RN;
    Diagn Microbiol Infect Dis; 2002 Nov; 44(3):289-99. PubMed ID: 12493177
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antimicrobial susceptibilities of urinary extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae to fosfomycin and nitrofurantoin in a teaching hospital in Taiwan.
    Liu HY; Lin HC; Lin YC; Yu SH; Wu WH; Lee YJ
    J Microbiol Immunol Infect; 2011 Oct; 44(5):364-8. PubMed ID: 21524974
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Change in the Annual Antibiotic Susceptibility of
    Kim YJ; Lee JM; Cho J; Lee J
    J Korean Med Sci; 2019 Sep; 34(34):e228. PubMed ID: 31456383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Molecular characteristics and antibiotic resistance profiles of Escherichia coli strains isolated from urinary tract infections in children admitted to children's referral hospital of Qom, Iran.
    Pourakbari B; Mamishi S; Shokrollahi MR; Heydari H; Mahmoudi S; Banar M; Sadeghi RH; Movahedi Z
    Ann Ig; 2019; 31(3):252-262. PubMed ID: 31069370
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Escherichia coli from community-acquired urinary tract infections resistant to fluoroquinolones and extended-spectrum beta-lactams.
    Kariuki S; Revathi G; Corkill J; Kiiru J; Mwituria J; Mirza N; Hart CA
    J Infect Dev Ctries; 2007 Dec; 1(3):257-62. PubMed ID: 19734602
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extended-spectrum beta-lactamase-producing Enterobacteriaceae in hospital urinary tract infections: incidence and antibiotic susceptibility profile over 9 years.
    Toner L; Papa N; Aliyu SH; Dev H; Lawrentschuk N; Al-Hayek S
    World J Urol; 2016 Jul; 34(7):1031-7. PubMed ID: 26511749
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antimicrobial Resistance in Hospitalized Patients with Community Acquired Urinary Tract Infection in Isfahan, Iran.
    Mostafavi SN; Rostami S; Rezaee Nejad Y; Ataei B; Mobasherizadeh S; Cheraghi A; Haghighipour S; Nouri S; Pourdad A; Ataabadi P; Almasi N; Heidary L; Naderi K; Korangbeheshti S; Navabi S; Masssah L; Norouzi Z; Bakhtiyaritabar M; Moayednia S; Shokri D; Mikhak M; Rahmani M; Hashemi M; Etminani R; Ahmadi N; Kelishadi R
    Arch Iran Med; 2021 Mar; 24(3):187-192. PubMed ID: 33878876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antibiotic resistance of urinary tract pathogens and evaluation of empirical treatment in Turkish children with urinary tract infections.
    Yüksel S; Oztürk B; Kavaz A; Ozçakar ZB; Acar B; Güriz H; Aysev D; Ekim M; Yalçinkaya F
    Int J Antimicrob Agents; 2006 Nov; 28(5):413-6. PubMed ID: 17000085
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Stratification by demographic and clinical data of the antibiotic susceptibility of Escherichia coli from urinary tract infections of the community.
    Grados MC; Thuissard IJ; Alós JI
    Aten Primaria; 2019 Oct; 51(8):494-498. PubMed ID: 30104087
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 44.